HUP2000298A1 - Vírusfertõzés, elõnyösen SARS-COV-2 és IBV koronavírusok fertõzésének visszaszorítására alkalmazható táplálék-kiegészítõ vagy gyógyászati vagy gyógyszerkészítmény és formulálásuk - Google Patents

Vírusfertõzés, elõnyösen SARS-COV-2 és IBV koronavírusok fertõzésének visszaszorítására alkalmazható táplálék-kiegészítõ vagy gyógyászati vagy gyógyszerkészítmény és formulálásuk

Info

Publication number
HUP2000298A1
HUP2000298A1 HU2000298A HUP2000298A HUP2000298A1 HU P2000298 A1 HUP2000298 A1 HU P2000298A1 HU 2000298 A HU2000298 A HU 2000298A HU P2000298 A HUP2000298 A HU P2000298A HU P2000298 A1 HUP2000298 A1 HU P2000298A1
Authority
HU
Hungary
Prior art keywords
ibv
coronaviruses
cov
medicinal
formulation
Prior art date
Application number
HU2000298A
Other languages
English (en)
Hungarian (hu)
Inventor
Laszlo Gyulai
Sardi Eva Dr
Nemeth Zsolt Istvan Dr
Original Assignee
Laszlo Gyulai
Sardi Eva Dr
Nemeth Zsolt Istvan Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laszlo Gyulai, Sardi Eva Dr, Nemeth Zsolt Istvan Dr filed Critical Laszlo Gyulai
Priority to HU2000298A priority Critical patent/HUP2000298A1/hu
Priority to EP21890365.6A priority patent/EP4210505A2/de
Priority to PCT/HU2021/000014 priority patent/WO2022112806A2/en
Publication of HUP2000298A1 publication Critical patent/HUP2000298A1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HU2000298A 2020-09-11 2020-09-11 Vírusfertõzés, elõnyösen SARS-COV-2 és IBV koronavírusok fertõzésének visszaszorítására alkalmazható táplálék-kiegészítõ vagy gyógyászati vagy gyógyszerkészítmény és formulálásuk HUP2000298A1 (hu)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HU2000298A HUP2000298A1 (hu) 2020-09-11 2020-09-11 Vírusfertõzés, elõnyösen SARS-COV-2 és IBV koronavírusok fertõzésének visszaszorítására alkalmazható táplálék-kiegészítõ vagy gyógyászati vagy gyógyszerkészítmény és formulálásuk
EP21890365.6A EP4210505A2 (de) 2020-09-11 2021-11-10 Nahrungsergänzungsmittel oder arzneimittel oder arzneimittel zur hemmung von virusinfektionen, vorteilhafterweise infektion mit sars-cov-2 und ibv-coronaviren und formulierung davon
PCT/HU2021/000014 WO2022112806A2 (en) 2020-09-11 2021-11-10 Food supplement or medicinal or pharmaceutical composition inhibiting virus infection, advantageously infection of sars-cov-2 and ibv coronaviruses and formulation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU2000298A HUP2000298A1 (hu) 2020-09-11 2020-09-11 Vírusfertõzés, elõnyösen SARS-COV-2 és IBV koronavírusok fertõzésének visszaszorítására alkalmazható táplálék-kiegészítõ vagy gyógyászati vagy gyógyszerkészítmény és formulálásuk

Publications (1)

Publication Number Publication Date
HUP2000298A1 true HUP2000298A1 (hu) 2022-03-28

Family

ID=89993188

Family Applications (1)

Application Number Title Priority Date Filing Date
HU2000298A HUP2000298A1 (hu) 2020-09-11 2020-09-11 Vírusfertõzés, elõnyösen SARS-COV-2 és IBV koronavírusok fertõzésének visszaszorítására alkalmazható táplálék-kiegészítõ vagy gyógyászati vagy gyógyszerkészítmény és formulálásuk

Country Status (3)

Country Link
EP (1) EP4210505A2 (de)
HU (1) HUP2000298A1 (de)
WO (1) WO2022112806A2 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914815A (pt) * 1998-10-30 2001-07-03 Merck Patent Gmbh Composições para tratamento e prevenção de doenças cardiovasculares
BRPI0311909A8 (pt) * 2002-06-19 2018-02-06 Nutricia Nv Métodos para a manufatura de uma composição, e para aumentar a capacidade de metilação de um indivíduo, e, composição farmacêutica ou nutricional
WO2018104909A2 (en) * 2016-12-09 2018-06-14 St. Jude Children's Research Hospital Dna methylation profiling for t-cell immunotherapy
WO2021202245A1 (en) * 2020-04-02 2021-10-07 Egaceutical Corporation Viral treatment regimens

Also Published As

Publication number Publication date
EP4210505A2 (de) 2023-07-19
WO2022112806A2 (en) 2022-06-02
WO2022112806A3 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
EA201101518A1 (ru) Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии
MX2022010964A (es) Composicion que comprende una avenantramida o un analogo de la misma con estabilidad mejorada.
BR112022010574A2 (pt) Composições farmacêuticas compreendendo cabotegravir
WO2010111650A3 (en) Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
ZA202108771B (en) Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereof
PH12012502085A1 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
ZA202300259B (en) Compound for the treatment of coronaviral infections
WO2014003536A8 (en) Dosage regime of fusion compounds
EP4094774A4 (de) Verwendung von interferon zur herstellung eines arzneimittels zur vorbeugung von coronavirus-infektionen oder zur vorbeugung von durch coronavirus-infektionen verursachten krankheiten
WO2016159582A3 (ko) 형개 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물
SG10202001341QA (en) Sterile or sterilized package for administration of medicinal or nutritional substances
HUP2000298A1 (hu) Vírusfertõzés, elõnyösen SARS-COV-2 és IBV koronavírusok fertõzésének visszaszorítására alkalmazható táplálék-kiegészítõ vagy gyógyászati vagy gyógyszerkészítmény és formulálásuk
FR2966016B1 (fr) Hydrolysats de proteines animales d'origine marine aux proprietes neuroprotectrices
EP3973976A4 (de) Pharmazeutische zusammensetzung mit extrakt aus camellia japonica als wirkstoff zur vorbeugung und behandlung von virusinfektionen
EP4230209A4 (de) Pharmazeutische zusammensetzung, pharmazeutische kombination und kombinations-kit zur prävention oder behandlung von chronischer hepatitis b
NZ599039A (en) Picrorhiza kurroa extract for prevention, elimination and treatment of rna viruses and infection or diseases caused by the same in humans, animals and in biotech industry
BRPI0413714A (pt) frações de leite e preparações de leite para tratamento e/ou prevenção de doenças mediadas por cox-2
CA3261961A1 (en) Lipoligourates, pharmaceutical composition and lipooligourates intended for use as a medicinal product
BR112015002726A8 (pt) combinação, composição farmacêutica, kit, e, usos de uma combinação, e de uma composição farmaceutica
DE602004025103D1 (de) Heilkräuterzusammensetzung zur Behandlung von AIDS
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone
IL296533B2 (en) History of tetrazoles, their preparation and pharmaceutical preparations containing them
Darkal et al. Composition, Nutritional and Health Benefits
HUP2000094A1 (hu) Gyógyászati és/vagy gyógyszerkészítmény intravezikális instillációra, elõállításuk és alkalmazásuk
MX2022010949A (es) Composiciones de avenantramida con solubilidad mejorada que comprenden 4-hidroxifenona.

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished